Abstract:Background: Multiplatform molecular subtyping has been put into clinical practice as an alternative for The Cancer Genome Atlas (TCGA)-based classification for endometrial cancer (EC), which proved a tool for predicting prognosis and guiding treatment. The traditional methods for the molecular classification of EC only based on pathological indicators are not accurate. The present study aimed to classify EC on a molecular level and explored the possibility of a one-time solution to guide clinical treatment and prognosis determination by utilizing data from a next-generation sequencing (NGS) panel. The ultimate aim was to utilize multiplatform testing to overcome disadvantages of long detection periods and limitations in the information regarding genetic variation. Methods: An NGS-panel was produced using FFPE samples isolated from 86 patients pathologically diagnosed with EC, and molecular subtyping was performed according to the recommended criteria. In addition, 45 matched samples from 86 patients were randomly selected for immunohistochemical (IHC) staining of P53, MLH1, MSH2, PMS2, and MSH6. Another 41 samples were not analyzed due to incomplete IHC staining results. SPSS (V26.0; IBM Corp., Armonk, NY, USA) was used for receiver operating characteristic (ROC) curve analysis. Results: The molecular typing ratio of the 86 cases of endometrial carcinoma was calculated to be 16.28% for POLE type, 17.44% for MSI-H type, 47.67% for CN-L type, 12.79% for CN-H type, 5.81% for unclassified case. A comparison between IHC ProMisE-based subtyping and NGS-based subtyping of the 45 cases revealed that 3 cases were classified as MSI-H by IHC but as MSS by NGS. Among these cases, 1 case was deficient in MLH1 expression and PMS2 protein expression but had wild-type P53 protein, and the P53 sequencing data of this sample showed a missense mutation. Good overall consistency between the 2 determination methods was shown. Receiver operating characteristic (ROC) analysis showed that NGS had particularly high specificity and sensitivity for detecting the MSI and CN subtypes [area under the curve (AUC) =0.893>0.5, P=0.000029<0.01]. Conclusions: The present study suggested that NGS-based subtyping could serve as an effective approach for the molecular typing of EC. Both NGS and IHC bear their own unique advantages and challenges in clinical practice.

Mechanisms of beta-lactam resistance in anaerobic bacteria.

Ka-band user antennas for VHTS GEO applications

Molecular Classification of Endometrial Cancers Using an Integrative DNA Sequencing Panel

Validation of a one-step genomics-based molecular classifier for endometrial carcinoma in a large Chinese population

The emerging role of molecular pathology in directing the systemic treatment of endometrial cancer

Prospective Clinical Prognostication of Endometrial Carcinomas Based on Next-Generation Sequencing and Immunohistochemistry-Real-World Implementation and Results at a Tertiary Care Center

A new strategy in molecular typing: the accuracy of an NGS panel for the molecular classification of endometrial cancers

Identification of molecular subtypes for endometrial carcinoma using a 46-gene next-generation sequencing panel: a retrospective study on a consecutive cohort

Molecular Classification of Endometrial Cancer of Chinese Population.

Genetic and molecular subtype heterogeneity in newly diagnosed early- and advanced-stage endometrial cancer

Molecular Classification Outperforms Histologic Classification in Prognostication of High-grade Endometrial Carcinomas With Undifferentiated and Sarcomatous Components

Application of NGS molecular classification in the diagnosis of endometrial carcinoma: A supplement to traditional pathological diagnosis

Molecular classification grade 3 endometrial endometrioid carcinoma using a next-generation sequencing-based gene panel

Molecular classification of metastatic and recurrent endometrial endometrioid carcinoma: prognostic relevance among low‐ and high‐stage tumours

Molecular classification of endometrial carcinoma applied to endometrial biopsy specimens: Towards early personalized patient management

Tarnished jewel.

An Incremental FP-Growth Web Content Mining and Its Application in Preference Identification

Comprehensive immunomolecular profiling of endometrial carcinoma: A tertiary retrospective study

Mechanical flange forming in steel and copper foil

787P A NGS Panel for Molecular Classification of Endometrial Carcinoma

[A rare cause of retroperitoneal fibrosis: actinomycosis].